{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-26-000997","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2026-08-03T13:00:14+00:00","discovered_at":"2026-08-03T13:01:00.337709+00:00","generated_at":"2026-08-03T13:01:09.195218+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"The Oncology Institute rebrands as Starling Oncology; ticker changes to STLN","bullets":["Company name changed to Starling Oncology, Inc. effective July 28, 2026.","Common stock ticker symbol changes from TOI to STLN effective August 4, 2026.","No stockholder approval required; CUSIP number remains 68236X100.","CEO Dan Virnich says rebrand reflects scale and coordinated care model.","Patient care unaffected; same phone numbers and portal access maintained."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-26-000997","json":"https://secwatch.observer/filing/0001079973-26-000997.json","markdown":"https://secwatch.observer/filing/0001079973-26-000997.md","text":"https://secwatch.observer/filing/0001079973-26-000997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000997/0001079973-26-000997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000997/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T13:01:09.195218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}